Correlation Between Salarius Pharmaceuticals and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Monopar Therapeutics, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Monopar Therapeutics.
Diversification Opportunities for Salarius Pharmaceuticals and Monopar Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Salarius and Monopar is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and Monopar Therapeutics
Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 3.29 times more return on investment than Monopar Therapeutics. However, Salarius Pharmaceuticals is 3.29 times more volatile than Monopar Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.39 per unit of risk. If you would invest 163.00 in Salarius Pharmaceuticals on November 9, 2024 and sell it today you would earn a total of 38.00 from holding Salarius Pharmaceuticals or generate 23.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salarius Pharmaceuticals vs. Monopar Therapeutics
Performance |
| Timeline |
| Salarius Pharmaceuticals |
| Monopar Therapeutics |
Salarius Pharmaceuticals and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salarius Pharmaceuticals and Monopar Therapeutics
The main advantage of trading using opposite Salarius Pharmaceuticals and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |